コメント 0

2018年 英文

原著

1)   Abematsu T, Okamoto Y, Nakagawa S, Kurauchi K, Kodama Y, Nishikawa T, Tanabe T, Shinkoda Y, Hatanaka M, Yoshioka T, Kawano Y. Early suspicion of disseminated cutaneous mucormycosis leading to successful treatment after bone marrow transplantation in a patient with acute myeloid leukemia. The Japanese Journal of Pediatric Hematology/Oncology vol. 55(3): 298–303, 2018

2)      Hazeki D, Ninomiya Y, Ueno K, Yoshinaga M. Tentative Screening Criteria for Short QT Interval in Children and Adolescents. Circ J. 2018;82:2627-2633.

3)      Imoto Y, Matsuba T, Kanda H, Ogata Y, Nagatomi S, Ueno K. Reimplantation of an anomalous left coronary artery with a malignant course. Asian Cardiovasc Thorac Ann. 2018;26:473-475.

4)   Itesako T, Eura R, Okamoto Y, Tatarano S, Yoshino H, Nishimura H, Yamada Y, Enokida H, Nakagawa M. Oral Propranolol in a Child With Infantile Hemangioma of the Urethra. Urology. 2018 Dec;122:165-168.

5)      Kirino Y, Kawaguchi Y, Tada Y, Tsukamoto H, Ota T, Iwamoto M, Takahashi H, Nagasawa K, Takei S, Horiuchi T, Ichida H, Minota S, Ueda A, Ohta A, Ishigatsubo Y. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still’s disease: A multicenter retrospective study. Mod Rheumatol. 2018 Sep;28(5):858-864.

6)   Koh K, Kato M, Saito AM, Kada A, Kawasaki H, Okamoto Y, Imamura T, Horibe K, Manabe A. Phase II/III study in children and adolescents with newly diagnosed B-cell precursor acute lymphoblastic leukemia: protocol for a nationwide multicenter trial in Japan. Jpn J Clin Oncol. 2018 Jul 1;48(7):684-691. doi: 10.1093/jjco/hyy071.

7)      Kubota T, Takei S, Shimizu M, Yasumura J, Nakagishi Y, Kizawa T, Yashiro M, Wakiguchi H, Yamasaki Y, Kawano Y. Early prediction for over two years efficacy of the first biologic agent for polyarticular uvenile idiopathic arthritis: A multi-institutional study in Japan. Mod Rheumatol. 2018 Sep;28(5):826-831.

8)      Matsunaga M, Kodama Y, Maruyama S, Miyazono A, Seki S, Tanabe T, Yoshimura M, Nishi J, Kawano Y. Guillain-Barré syndrome and optic neuritis after Mycoplasma pneumoniae infection. Brain Dev 2018; 40(5): 439-442

9)      Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, Kawaguchi Y, Kono H, Takasaki Y, Takei S, Nishimoto N, Fujimoto M, Asanuma YF, Mimori A, Okiyama N, Kaneko S, Takahashi H, Yokosawa M, Sumida T. Evidence-based clinical practice guideline for adult Still’s disease. Mod Rheumatol. 2018 Sep;28(5):736-757.

10)   Mori M, Sugiyama N, Morishima Y, Sugiyama N, Kokubo T, Takei S, Yokota S.  Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance. Mod Rheumatol. 2018 Jan;28(1):101-107.

11)   Nakagawa S, Okamoto Y, Kodama Y, Nishikawa T, Tanabe T, Kawano Y. Thiamylal Plus Pentazocine Shows Similar Efficacy as Ketamine Plus Midazolam for Painful Procedures in Children With Leukemia. J Pediatr Hematol Oncol. 2018 May;40(4):e263-e265. doi: 10.1097/MPH.0000000000001053.

12)      Nakano N, Mori M, Umebayashi H, Iwata N, Kobayashi N, Masunaga K, Imagawa T, Murata T, Kinjo N, Nagai K, Miyoshi M, Takei S, Yokota S, Ishii E. Characteristics and outcome of intractable vasculitis syndrome in children: Nation-wide survey in Japan. Mod Rheumatol. 2018 Jul;28(4):697-702.

13)      Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N.  Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis. 2018 Mar;77(3):348-354.

14)   Ohmori H, Nakamura M, Kada A, Saito AM, Sanayama Y, Shinagawa T, Fujita H, Wakisaka A, Maruhashi K, Okumura A, Takizawa N, Murata H, Inoue M, Kaneko H, Taniguchi H, Kawasaki M, Sano N, Akaboshi S, Tanuma N, Sone S, Kumode M, Takechi T, Koretsune Y, Sumimoto R, Miyanomae T. Multicenter,Opne-Label,Randomized Controlled Trial of Warfarin and Edoxaban Tosilate Hydrate for the Treatment of Deep Vein Thrombosis in Persons with Severe Motor Intellectual Disabilities Kurume Medical Journal 2018 Dec 21; 65(1): 11-16

15)    Okamoto N, Yokota S, Takei S, Okura Y, Kubota T, Shimizu M, Nozawa T, Iwata N, Umebayashi H, Kinjo N, Kunishima T, Yasumura J, Mori M. Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018. Mod Rheumatol. 2019 Jan;29(1):41-59.

16)   Saito A, Ohno S, Nuruki N, Nomura Y, Horie M, Yoshinaga M. Three cases of catecholaminergic polymorphic ventricular tachycardia with prolonged QT intervals including two cases of compound mutations. J Arrhythm 2018;34(3):291-293.

17)   Seki S, Yamashita E, Tanoue K, Nuruki N, Sonoda M, Ohno S, Ishibashi-Ueda H, Tanaka Y, Yoshinaga M. Pre-diagnostic electrocardiographic and echocardiographic images of biopsy-proven hypertrophic cardiomyopathy. J Arrhythm. 2018 Aug 31;34(6):643-646

18)   Seki Y, Okamoto Y, Kodama Y, Nishikawa T, Tanabe T, Nakagawa S, Mizota M, Kawano Y. Risk Factors and the Prevention of Weight Gain During Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2018 Aug;40(6):e334-e337. doi: 10.1097/MPH.0000000000001098.

19)   Yuge K, Iwama K, Yonee C, Matsufuji M, Sano N, Saikusa T, Yae Y, Yamashita Y, Mizuguchi T, Matsumoto N, Matsuishi T. A novel STXBP1 mutation causes typical Rett syndrome in a Japanese girl Brain & development 2018 Jun; 40(6): 493-497

コメントを残す

以下に詳細を記入するか、アイコンをクリックしてログインしてください。

WordPress.com ロゴ

WordPress.com アカウントを使ってコメントしています。 ログアウト /  変更 )

Google フォト

Google アカウントを使ってコメントしています。 ログアウト /  変更 )

Twitter 画像

Twitter アカウントを使ってコメントしています。 ログアウト /  変更 )

Facebook の写真

Facebook アカウントを使ってコメントしています。 ログアウト /  変更 )

%s と連携中